
"ZYMGREOPriority claimed from 30/07/2019; Application No. : 88550785 ;United States of America" is still moving through the registration pipeline. Most applications hit at least one hurdle — objection, opposition or a hearing — and deadlines at each stage are short. Get notified the moment the status changes.
| Trademark | ZYMGREOPriority claimed from 30/07/2019; Application No. : 88550785 ;United States of America |
| Trademark Type | Wordmark |
| Class | 5 |
| Application Number | 4252322 |
| Nature/Scope of business | pharmaceutical preparations, namely, medications for the treatment of ischemic stroke, hemorrhagic stroke, transient ischemic attack, alzheimer's disease, parkinson's disease, mixed dementia, frontotemporal dementia, dementia with lewy bodies, vascular dementia, wernicke-korsakoff syndrome, huntington's disease, creutzfeldt jakob disease, normal pressure hydrocephalus, spinal cord injury, traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, hypoxic-ischemic injury to the brain or spinal cord and neurodegenerative diseases. |
| Publication | In Journal No. 1918 |
| Status | DRAFT |
| Applicant: | PHARMAZZ, INC. |
| Applicant Address | Suite 106, 50 West 75th Street, Willowbrook, Illinois, United States, 60527 A company incorporated under the laws of United States of America |
| Jurisdiction | DELHI |
| Agent | LUTHRA & LUTHRA LAW OFFICES |
| Agent Address | 103 ASHOKA ESTATE 24 BARAKHAMBA ROAD, NEW DELHI-1 |
Get your trademark registered with expert guidance. Limited time offer!
File NowComprehensive analysis of your trademark search delivered to your phone
What you'll get: